CROATEST (R) RHEUMATOID DIAGNOSTIC— 510(k) K904416

Substantially Equivalent

Biotrax, Inc.

FDA 510(k) clearance K904416 for CROATEST (R) RHEUMATOID DIAGNOSTIC, Substantially Equivalent on 1991-06-24. Applicant: Biotrax, Inc..

Clearance details

Applicant
Biotrax, Inc.
Product code
Code GTQ
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Baltimore, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.